BridgeMD
New treatment option for Mental Health Issue
Official title Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents
ClinicalTrials.gov ID: NCT05766592
What this study is testing
- What it's testing
- The purpose of this study is to assess the efficacy of an LGBTQ-affirmative individual cognitive behavioral psychotherapy (CBT) and LGBTQ-affirmative family therapy (attachment-based family therapy for sexual and gender minority young adults; ABFT-SGM) delivered via telehealth to a sample of sexual and gender minority adults with nonaccepting parent(s) in New York, Pennsylvania, Connecticut, and Israel. The investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- be 20 and older
- be fluent in English
- self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity
- currently experience elevated depressive or anxiety symptoms (screened initially using a cutoff of ≥ 2.5 on the Brief Symptom Inventory-4 and further...
- report at least moderate levels of parental rejection or low levels of parental acceptance, as measured using the PARSOS.
You likely can't join if
- report current mental health treatment ≥1 day/month (except for medication management ≤1 day/week)
- report beginning a new medication within the past 30 days
- exhibit active psychosis or active mania, as assessed by the SCID-Psych Screen.
- exhibit active suicidality or active homicidality, as assessed by the SIDAS
- be currently legally mandated to attend treatment
- demonstrate gross cognitive impairment, as assessed with the Telephone Interview for Cognitive Status
See the full eligibility criteria
- be 20 and older
- be fluent in English
- self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity
- currently experience elevated depressive or anxiety symptoms (screened initially using a cutoff of ≥ 2.5 on the Brief Symptom Inventory-4 and further confirmed by the BDI and BAI).
- report at least moderate levels of parental rejection or low levels of parental acceptance, as measured using the PARSOS.
- have at least one rejecting/nonaccepting parent that agrees to participate in the therapy.
- live in New York State, Pennsylvania, Connecticut, or Israel.
- report current mental health treatment ≥1 day/month (except for medication management ≤1 day/week)
- report beginning a new medication within the past 30 days
- exhibit active psychosis or active mania, as assessed by the SCID-Psych Screen.
- exhibit active suicidality or active homicidality, as assessed by the SIDAS
- be currently legally mandated to attend treatment
- demonstrate gross cognitive impairment, as assessed with the Telephone Interview for Cognitive Status
- do not have a parent willing to participate
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
- Beersheba, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States; Beersheba, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.